The authors reported up-regulation of Sema3C and downregulation of Sema3A and Sema3E levels after exposure to hypoxia or hypoxic mimetic agents, thus suggesting a different role of Sema3 family members in the progression of prostate cancer [37]. Here, SEMA3C is linked to prostate carcinoma.